EU anti-trust regulators have closed their investigation into Edwards Lifesciences (EW) after the Co. withdrew anti-copycat policy

The closure of the EU anti-trust investigation into Edwards Lifesciences is significant as it alleviates regulatory pressure, which could enhance investor sentiment towards the stock.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

US Secretary of State Rubio says that US President Trump is deeply committed to Hungary's PM Orban's success and will support Orban if Hungary encounters any trouble

Hungary's PM Orban assures US Secretary of State Rubio, that he still backs the US peace effort in Ukraine; Hungary still open to hosting peace summit

EU anti-trust regulators have closed their investigation into Edwards Lifesciences (EW) after the Co. withdrew anti-copycat policy

The IRGC naval forces are conducting manoeuvres in the Strait of Hormuz to test readiness and review military operations to confront threats, Al Jazeera reports citing Iranian TV

UK's PM Starmer on defence spending, says they need to move faster

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This move also removes uncertainty regarding potential penalties or operational changes, allowing the company to focus on growth strategies. Overall, expect this development to positively influence Edwards' market positioning within the healthcare equipment sector.

Related headlines

The whole workspace, free to try.

Try it free